University of Alabama Birmingham: Cellular Metabolism Regulates Fate Decision Between Pathogenic, Regulatory T Cells
February 26, 2020
February 26, 2020
BIRMINGHAM, Alabama, Feb. 26 [TNSmedicalresearch] -- The University of Alabama Birmingham campus issued the following news:
Patients with autoimmune diseases like multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis have an imbalance between two types of immune system T cells. Destructive Th17 cells that mediate chronic inflammation are elevated, and regulatory T cells, or Treg cells, which suppress inflammatory responses and play a protective role in autoimmune d . . .
Patients with autoimmune diseases like multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis have an imbalance between two types of immune system T cells. Destructive Th17 cells that mediate chronic inflammation are elevated, and regulatory T cells, or Treg cells, which suppress inflammatory responses and play a protective role in autoimmune d . . .